what are the tirzepatide doses Flex-Dose 1 mL Injectable 10 mg/mL TrimRX | Starting Dose of

Consider dosage reduction or discontinuation of QSYMIA if clinically significant or persistent symptoms occur

Administered as a once-weekly subcutaneous injection, tirzepatide is typically initiated at 2.5 mg and increased by 2.5 mg every 4 weeks to a target dose of 5-15 mg as tolerated

Package sizes may need to shrink

More noticeable and lasting results often develop gradually over three to six months, especially as the dose is slowly increased and patients reach their maintenance dose

Specifically, GLP-1 agonists increased expression of the progesterone receptor, and the combination of the two agents resulted in more pronounced cell death as compared to a single agent alone